Download Citation
Article Source:
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
Miranda-Verastegui C,
Tulliano G,
Gyorkos TW,
Calderon W,
Rahme E,
et al.
(2009)
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony.
PLOS Neglected Tropical Diseases 3(7): e491.
https://doi.org/10.1371/journal.pntd.0000491